Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Altamira Therapeutics Ltd

Altamira Therapeutics’ SemaPhore Delivery Platform Shows Significant Synergis-tic Effects of ZBTB46 mRNA with PD1 Immunotherapy in Control of Tumor Growth in Animal Model
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Provides Business Update
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Provides Update on Clinical Trials with Bentrio
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics to Present at 2nd Annual mRNA-Based Therapeutics Summit Europe Conference January 24th to 26th
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Provides Year-End 2022 Business Update
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics to Participate at TIDES Europe Oligonucleotide and Peptide Therapeutics Hybrid Event
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Regains Listing Compliance with NASDAQ Minimum Bid Requirement
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Data Published in Peer-Reviewed Journal Demonstrate Protective Effects of Altamira’s Bentrio under Controlled Grass Pollen Exposure
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Announces Reverse Stock Split
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Announces Divestiture of Inner Ear Development Assets
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics to Participate at RNA Leaders USA Congress
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics Continue Bentrio Clinical Trial for Seasonal Allergic Rhinitis in Australia
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Altamira Therapeutics’ Delivery Platform with siRNA Shown to be Effective Treatment for Osteoarthritis as Published in Peer-Reviewed Journal
From Altamira Therapeutics Ltd
Via GlobeNewswire
Tickers CYTO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.